These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 37376587)

  • 41. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic complications of COVID-19 and its treatment.
    Tian D; Ye Q
    J Med Virol; 2020 Oct; 92(10):1818-1824. PubMed ID: 32437004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
    Bhatnagar J; Gary J; Reagan-Steiner S; Estetter LB; Tong S; Tao Y; Denison AM; Lee E; DeLeon-Carnes M; Li Y; Uehara A; Paden CR; Leitgeb B; Uyeki TM; Martines RB; Ritter JM; Paddock CD; Shieh WJ; Zaki SR
    J Infect Dis; 2021 Mar; 223(5):752-764. PubMed ID: 33502471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytokine storm induced by SARS-CoV-2.
    Song P; Li W; Xie J; Hou Y; You C
    Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management.
    Antar SA; Ashour NA; Hamouda AO; Noreddin AM; Al-Karmalawy AA
    Inflammopharmacology; 2024 Oct; 32(5):2649-2680. PubMed ID: 39126569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 and comorbidities of hepatic diseases in a global perspective.
    Ahmad A; Ishtiaq SM; Khan JA; Aslam R; Ali S; Arshad MI
    World J Gastroenterol; 2021 Apr; 27(13):1296-1310. PubMed ID: 33833483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?
    Ozieranski K; Tyminska A; Jonik S; Marcolongo R; Baritussio A; Grabowski M; Filipiak KJ; Opolski G; Caforio ALP
    J Card Fail; 2021 Jan; 27(1):92-96. PubMed ID: 33166657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
    Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
    Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
    Rossouw TM; Anderson R; Manga P; Feldman C
    Front Immunol; 2022; 13():776861. PubMed ID: 35185878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver injury in severe COVID-19 infection: current insights and challenges.
    Ali N; Hossain K
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):879-884. PubMed ID: 32649840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of COVID-19 pathogenesis in diabetes.
    Aluganti Narasimhulu C; Singla DK
    Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H403-H420. PubMed ID: 35776683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver dysfunction and SARS-CoV-2 infection.
    Gracia-Ramos AE; Jaquez-Quintana JO; Contreras-Omaña R; Auron M
    World J Gastroenterol; 2021 Jul; 27(26):3951-3970. PubMed ID: 34326607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver-spleen axis dysfunction in COVID-19.
    Cococcia S; Lenti MV; Santacroce G; Achilli G; Borrelli de Andreis F; Di Sabatino A
    World J Gastroenterol; 2021 Sep; 27(35):5919-5931. PubMed ID: 34629809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SARS-CoV-2 triggering autoimmune diseases.
    Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
    Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COVID-19 and the liver: What do we know so far?
    Nasa P; Alexander G
    World J Hepatol; 2021 May; 13(5):522-532. PubMed ID: 34131467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COVID-19 and liver dysfunction: Epidemiology, association and potential mechanisms.
    Du M; Yang S; Liu M; Liu J
    Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101793. PubMed ID: 34428501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.